Bacterial contamination remains a critical concern in the environmental and biomedical fields, driving the demand for multifunctional materials with reliable antibacterial properties. Cellulose acetate–graphene oxide (CA–GO) composites, as a class of polymer nanocomposites, offer an effective solution by combining the biocompatibility of cellulose acetate with the antimicrobial activity of graphene oxide. In this study, the antibacterial performance of CA–GO composites was systematically evaluated by using multiple analytical techniques to better understand their efficacy under diverse conditions. A suite of complementary methods, including the Contact Film Diffusion Assay, Surface Drop Viability Assay, and Dynamic Immersion Exposure Test, was employed to assess how variables such as GO concentration, bacterial strain type, and exposure settings influence antibacterial activity. Results showed that CA–GO composites exhibit strong antibacterial effects, particularly against Gram-positive bacteria, largely attributed to GO’s ability to disrupt bacterial membrane integrity through oxidative stress and physical interactions. This multimethod investigation highlights the importance of testing under varied conditions to capture the full spectrum of antibacterial behavior. The findings not only demonstrate the high potential of CA–GO composites for antimicrobial applications but also underscore the need for standardized evaluation protocols tailored to graphene-based polymer nanocomposites.
The investigation of established pharmaceutical agents for recalibrating usage strongly supplements new drug development. In this work, we have prepared coassembled complexes of acetazolamide (AZM) with the cationic peptide octaarginine (R8) in an attempt to enhance its potency and scope of use. R8 and AZM in different weight ratios coassemble into remarkable nano- and microstructures such as ribbons, sheets, and stick-like structures. A combination of FTIR, XRD, SEM, and DSC has been used to characterize the R8:AZM coassemblies. The sulfonamide SO2 and NH2 groups of AZM are associated with the guanidinium amine, free amine, and terminal carbonyl groups of R8 resulting in distinctive topologies. Treatment of Escherichia coli with the complexes results in a distinctive pattern of membrane disruption and pore formation. The R8:AZM coassemblies inhibit carbonic anhydrase and E. coli growth with greater efficiency compared to bare AZM. The 1:5 w/w complex leads to pronounced outer and inner membrane rupture and significantly restricts glucose uptake by E. coli. The ability of R8 and AZM to coassemble into a distinctive set of structures based solely on differences in their relative proportions and their engagement with E. coli as more than the sum of their parts are novel facets of R8 and AZM behavior and underscore a straightforward and elegant approach for enhancing the scope of use of small molecule drugs.